FILANA THERAPEUTICS, INC.
Public companyAs of Nov 15, 2026, the newest executive change on record for FILANA THERAPEUTICS, INC. is the appointment of Jill M. Quigley as Class I director, in an SEC 8-K filed Nov 12, 2026.Updated
- Headquarters
- AUSTIN, Texas
- Ticker
- FLNA
- CIK
- 0001069530
WARN notices since 2024
Workers affected since 2024
Executive changes, last 12 months
Last event
Workers affected over time
Cumulative workers in WARN notices since 2024
Not enough notices to chart yet.
Leadership
| Role and person | Since | Change |
|---|---|---|
| Class I directorJill M. Quigley | Nov 12, 2026 | Appointed |
Related companies
Same industry, the same state first.
- CERENOME, INC.
Chief Business Officer appointed: Ronald A. Andrews
- GeoVax Labs, Inc.
director appointed: Shahin Behroyan
- BRISTOL MYERS SQUIBB CO
WARN notice: Princeton, NJ
- JOHNSON & JOHNSON
WARN notice: New Brunswick, NJ
- Merck & Co., Inc.
WARN notice: Rahway, NJ
- NOVO NORDISK A S
WARN notice: Plainsboro, NJ
- Executive appointment
Class I director appointed: Jill M. Quigley
Jill M. Quigley was named Class I director of FILANA THERAPEUTICS, INC., effective November 8, 2026. The company reported the change in an 8-K that cites Item 5.02.
Role: Class I director
Only one public record so far. We add events as soon as a new filing lands; watch FILANA THERAPEUTICS, INC. to get them in your digest.
Last verified Nov 12, 2026
Questions about FILANA THERAPEUTICS, INC.
- Did FILANA THERAPEUTICS, INC. change its Class I director?
- Yes. Jill M. Quigley was appointed Class I director of FILANA THERAPEUTICS, INC., reported in an SEC 8-K filed Nov 12, 2026. It is the newest executive change on record for FILANA THERAPEUTICS, INC. as of Nov 15, 2026.The SEC 8-K filingAll leadership changes